Asian Pacific Journal of Cancer Prevention

  • 제13권1호
  • /
  • Pages.247-250
  • /
  • 2012
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Expression of CDX2 and Villin in Gastric Cardiac Intestinal Metaplasia and the Relation with Gastric Cardiac Carcinogenesis

  • Xiao, Zhong-Yue (Department of Oncology, Cancer Institute, the First Affiliated Hospital of Henan University of Science and Technology) ;
  • Ru, Yi (Department of Oncology, Cancer Institute, the First Affiliated Hospital of Henan University of Science and Technology) ;
  • Sun, Jiang-Tao (Department of Oncology, Cancer Institute, the First Affiliated Hospital of Henan University of Science and Technology) ;
  • Gao, She-Gan (Department of Oncology, Cancer Institute, the First Affiliated Hospital of Henan University of Science and Technology) ;
  • Wang, Yu-Feng (Department of Oncology, Cancer Institute, the First Affiliated Hospital of Henan University of Science and Technology) ;
  • Wang, Li-Dong (Henan Key Laboratory for Esophageal Cancer Research, College of Medicine, Zhengzhou University) ;
  • Feng, Xiao-Shan (Department of Oncology, Cancer Institute, the First Affiliated Hospital of Henan University of Science and Technology)
  • 발행 : 2012.01.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: To determine whether CDX2 and villin protein expression are associated with intestinal metaplasia (IM) in gastric cardiac mucosa and to explore the relationship with evolution of gastric cardiac adenocarcinoma (GCA). Methods: We studied 143 gastric cardiac biopsy or resection specimens from Henan province China, including 25 cardiac gastritis specimens with IM, 65 dysplasia specimens with IM and 35 gastric cardiac adenocarcinoma specimens and stained them for CDX2 and villin by the immunohistochemical SP method. 15 normal gastric cardiac biopsy specimens were also collected as control. Results: (1) Normal gastric mucosa presented no CDX2 and villin expression. The positive rates of CDX2 protein in cardiac gastritis with IM, dysplasia with IM, and carcinoma tissues were 84.0% (21/25), 66.7% (32/48) and 36.4% (20/55), respectively. While the positive rates of villin protein in cardiac gastritis with IM, dysplasia with IM, and carcinoma tissues were 76.0% (19/25), 70.8% (34/48) and 45.5% (25/55), respectively. There were significant differences among the three groups for both CDX2 and villin (P<0.01). Spearman's rank correlation coefficient(rho) showed a close correlation between the two proteins (r=0.843, P<0.01) and both were positively related with tumor differentiation (both P<0.05), but not associated with age, sex, invasion and metastasis of lymph node (P>0.05). Conclusion: Our results suggest that ectopic expression of CDX2 and villin may be involved in early-stage IM and tumorigenesis in gastric cardia and the expression of villin may be regulated by CDX2.

키워드

참고문헌

  1. Athman R, Louvard D, Robine S (2002). The epithelial cell cytoskeleton and intracellular trafficking. III. How is villin involved in the actin cytoskeleton dynamics in intestinal cells? Am J Physiol Gastrointest Liver Physiol, 283, G496- 502. https://doi.org/10.1152/ajpgi.00207.2002
  2. Blot WJ, Devesa SS, Kneller RW, et al (1991). Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA, 265, 1287-9. https://doi.org/10.1001/jama.1991.03460100089030
  3. Botterweck AA, Schouten LJ, Volovics A, et al (2000). Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol, 29, 645-54. https://doi.org/10.1093/ije/29.4.645
  4. Dudouet B, Robine S, Huet C, et al (1987). Changes in villin synthesis and subcellular distribution during intestinal differentiation of HT29-18 clones. J Cell Biol, 105, 359-69. https://doi.org/10.1083/jcb.105.1.359
  5. Eda A, Osawa H, Satoh K, et al (2003). Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J Gastroenterol, 38, 14-22. https://doi.org/10.1007/s005350300001
  6. Eda A, Osawa H, Yanaka I, et al (2002). Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J Gastroenterol, 37, 94-100. https://doi.org/10.1007/s005350200002
  7. Fitzgerald RC, Omary MB, Triadafilopoulos G (1997). Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett's esophagus. J Cell Sci, 110, 663-71.
  8. Gao SG, Wang LD, Fan ZM, et al (2005). Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at high-incidence area in Henan, north China. World J Gastroenterol, 11, 4634-7. https://doi.org/10.3748/wjg.v11.i30.4634
  9. Guo RJ, Suh ER, Lynch JP (2004). The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther, 3, 593-601. https://doi.org/10.4161/cbt.3.7.913
  10. Kerkhof M, Bax DA, Moons LM, et al (2006). Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells? Aliment Pharmacol Ther, 24, 1613-21. https://doi.org/10.1111/j.1365-2036.2006.03163.x
  11. McColl KE (2006). Cancer of the gastric cardia. Best Pract Res Clin Gastroenterol, 20, 687-96. https://doi.org/10.1016/j.bpg.2006.03.005
  12. Mesquita P, Jonckheere N, Almeida R, et al (2003). Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines. J Biol Chem, 278, 51549-56. https://doi.org/10.1074/jbc.M309019200
  13. Mutoh H, Sakurai S, Satoh K, et al (2004). Development of gastric carcinoma from intestinal metaplasia in Cdx2- transgenic mice. Cancer Res, 64, 7740-7. https://doi.org/10.1158/0008-5472.CAN-04-1617
  14. Niwa T, Ikehara Y, Nakanishi H, et al (2005). Mixed gastricand intestinal-type metaplasia is formed by cells with dual intestinal and gastric differentiation. J Histochem Cytochem, 53, 75-85. https://doi.org/10.1177/002215540505300109
  15. Odze RD (2005). Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective. Am J Gastroenterol, 100, 1853-67. https://doi.org/10.1111/j.1572-0241.2005.50096.x
  16. Palli D, Bianchi S, Decarli A, et al (1992). A case-control study of cancers of the gastric cardia in Italy. Br J Cancer, 65, 263-6. https://doi.org/10.1038/bjc.1992.52
  17. Regalado SP, Nambu Y, Iannettoni MD, et al (1998). Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas. Mol Carcinog, 22, 182-9. https://doi.org/10.1002/(SICI)1098-2744(199807)22:3<182::AID-MC6>3.0.CO;2-N
  18. Shi XY, Bhagwandeen B, Leong AS (2008). CDX2 and villin are useful markers of intestinal metaplasia in the diagnosis of Barrett esophagus. Am J Clin Pathol, 129, 571-7. https://doi.org/10.1309/UWK3NAHV31GFHM3J
  19. Siewert JR, Stein HJ, Feith M (2006). Adenocarcinoma of the esophago-gastric junction. Scand J Surg, 95, 260-9. https://doi.org/10.1177/145749690609500409
  20. Silberg DG, Sullivan J, Kang E, et al (2002). Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology, 122, 689-96. https://doi.org/10.1053/gast.2002.31902
  21. Silberg DG, Swain GP, Suh ER, et al (2000). Cdx1 and cdx2 expression during intestinal development. Gastroenterology, 119, 961-71. https://doi.org/10.1053/gast.2000.18142
  22. Tsukamoto T, Inada K, Tanaka H, et al (2004). Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol, 130, 135-45. https://doi.org/10.1007/s00432-003-0519-6
  23. Villanacci V, Rossi E, Zambelli C, et al (2007). COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasiacarcinoma progression in Barrett's esophagus. Dig Liver Dis, 39, 305-11. https://doi.org/10.1016/j.dld.2007.01.011
  24. Weimann A, Rieger A, Zimmermann M, et al (2010). Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett's esophagus. Virchows Arch, 457, 537-45. https://doi.org/10.1007/s00428-010-0972-y
  25. Yamamichi N, Inada K, Furukawa C, et al (2009). Cdx2 and the Brm-type SWI/SNF complex cooperatively regulate villin expression in gastrointestinal cells. Exp Cell Res, 315, 1779-89. https://doi.org/10.1016/j.yexcr.2009.01.006
  26. Zhao CB, Zhou CJ, Guo JQ (2009). Expression of villin in precancerous lesions and gastric carcinoma and its clinical significance. J ShanDong University Med Sci, 47, 46-9

피인용 문헌

  1. Expression of β-arrestin 1 in Gastric Cardiac Adenocarcinoma and its Relation with Progression vol.13, pp.11, 2012, https://doi.org/10.7314/APJCP.2012.13.11.5671
  2. Induces Increased Expression of Toll-Like Receptors and Decreased Toll-Interacting Protein in Gastric Mucosa that Persists Throughout Gastric Carcinogenesis vol.18, pp.1, 2012, https://doi.org/10.1111/hel.12008
  3. Toll-Like Receptors as Biomarkers of Gastric Carcinogenesis: Implications for Diagnosis, Prognosis and Treatment vol.04, pp.05, 2013, https://doi.org/10.4236/jct.2013.45117
  4. Midkine and syndecan-1 levels correlate with the progression of malignant gastric cardiac adenocarcinoma vol.10, pp.3, 2014, https://doi.org/10.3892/mmr.2014.2369
  5. Features of Gastric and Colonic Mucosa in Congenital Enteropathies vol.38, pp.12, 2014, https://doi.org/10.1097/PAS.0000000000000287
  6. Overexpression of caudal type homeobox transcription factor 2 inhibits the growth of the MGC-803 human gastric cancer cell line in vivo vol.12, pp.1, 2015, https://doi.org/10.3892/mmr.2015.3413
  7. Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study vol.35, pp.10, 2015, https://doi.org/10.1007/s40261-015-0329-z
  8. HpSlyD inducing CDX2 and VIL1 expression mediated through TCTP protein may contribute to intestinal metaplasia in the stomach vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-02642-y